Kinetics of CA19-9 Decline in a Randomized Phase III Study of Irinotecan Liposome Injection, Oxaliplatin, 5-Fluorouracial/leucovorin (NALIRIFOX) or Nab-Paclitaxel Plus Gemcitabine (GEM+NABP) in Patients Who Have Not Previously Received Chemotherapy for Metastatic Adenocarcinoma of the Pancreas (NAPOLI 3).
Journal of Clinical Oncology（2024）
Key words
3282-415-5268-2723-6700,613-135-2370-7650-2700,283-237-267-6887,239,3618,193,16,4343,4343
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined